Bickhart, Derek M. http://orcid.org/0000-0003-2223-9285
Kolmogorov, Mikhail http://orcid.org/0000-0002-5489-9045
Tseng, Elizabeth
Portik, Daniel M. http://orcid.org/0000-0003-3518-7277
Korobeynikov, Anton http://orcid.org/0000-0002-2937-9259
Tolstoganov, Ivan http://orcid.org/0000-0003-1536-3296
Uritskiy, Gherman
Liachko, Ivan
Sullivan, Shawn T.
Shin, Sung Bong
Zorea, Alvah http://orcid.org/0000-0001-6543-2259
Andreu, Victòria Pascal http://orcid.org/0000-0001-9609-9401
Panke-Buisse, Kevin
Medema, Marnix H. http://orcid.org/0000-0002-2191-2821
Mizrahi, Itzhak http://orcid.org/0000-0001-6636-8818
Pevzner, Pavel A.
Smith, Timothy P. L. http://orcid.org/0000-0003-1611-6828
Article History
Received: 4 May 2021
Accepted: 13 October 2021
First Online: 3 January 2022
Competing interests
: The authors declare the following competing interests: M.H.M. is a co-founder of Design Pharmaceuticals and a member of the scientific advisory board of Hexagon Bio. E.T. and D.M.P. are employees of Pacific Biosciences. G.U. is an employee of Amazon. S.T.S. and I.L. are co-founders and the CTO and CEO, respectively, of Phase Genomics. The remaining authors declare no competing interests.